Tumor-infiltrating lymphocyte (TIL) therapy is a new treatment option for advanced or metastatic melanoma. Mayo Clinic Comprehensive Cancer Center in Jacksonville, Florida, is one of few centers in the Southeast offering TIL therapy.
FDA-approved TIL therapy combines high-dose chemotherapy and immune stimulation, reengineering your body’s own T-cells to target and destroy cancer cells. TIL therapy requires expert care in a hospital with advanced infrastructure. Mayo Clinic’s state-of-the-art hospital is uniquely equipped to deliver complex cell therapies requiring inpatient support.